UnitedHealth’s Acquisition of PBM Catamaran Heralds Escalating Price War With Drugmakers
Published: | Updated:
Last week’s announcement by UnitedHealth Group of its planned acquisition of pharmacy benefits manager (PBM) Catamaran for $12.8 billion officially puts the pharmaceutical industry on notice that the “war” on drug prices is escalating, writes Michael Griffith.